BlackRock Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $400M | Sell |
5,591,136
-55,717
| -1% | -$3.99M | 0.46% | 37 |
|
|
2016
Q3 | $447M | Buy |
5,646,853
+806,723
| +17% | +$63.8M | 0.55% | 30 |
|
|
2016
Q2 | $404M | Buy |
4,840,130
+881,262
| +22% | +$73.5M | 0.51% | 33 |
|
|
2016
Q1 | $364M | Buy |
3,958,868
+149,368
| +4% | +$13.7M | 0.47% | 38 |
|
|
2015
Q4 | $385M | Buy |
3,809,500
+505,626
| +15% | +$51.2M | 0.49% | 33 |
|
|
2015
Q3 | $324M | Buy |
3,303,874
+114,701
| +4% | +$11.3M | 0.44% | 45 |
|
|
2015
Q2 | $373M | Buy |
3,189,173
+216,981
| +7% | +$25.4M | 0.46% | 40 |
|
|
2015
Q1 | $292M | Sell |
2,972,192
-597,752
| -17% | -$58.7M | 0.38% | 53 |
|
|
2014
Q4 | $337M | Buy |
3,569,944
+49,976
| +1% | +$4.71M | 0.45% | 41 |
|
|
2014
Q3 | $375M | Sell |
3,519,968
-973,868
| -22% | -$104M | 0.52% | 33 |
|
|
2014
Q2 | $373M | Sell |
4,493,836
-457,013
| -9% | -$37.9M | 0.5% | 35 |
|
|
2014
Q1 | $351M | Buy |
4,950,849
+530,100
| +12% | +$37.6M | 0.51% | 35 |
|
|
2013
Q4 | $332M | Buy |
4,420,749
+352,535
| +9% | +$26.5M | 0.49% | 35 |
|
|
2013
Q3 | $256M | Buy |
4,068,214
+440,066
| +12% | +$27.7M | 0.42% | 44 |
|
|
2013
Q2 | $186M | Buy |
+3,628,148
| New | +$186M | 0.33% | 64 |
|